| Aetna | Aducanumab-avwa (Aduhelm) | 2024-10-01 |
| UHC Oxford Medical and Drug | Genetic Testing for Neuromuscular Disorders - Oxford Clinical Policy | 2024-10-01 |
| UHC Oxford Medical and Drug | Percutaneous Neuroablation for Pancreatic Cancer Pain, Severe Cancer Pain, and Trigeminal Neuralgia - Oxford Clinical Policy | 2024-10-01 |
| UHC Oxford Medical and Drug | Spinal Fusion and Bone Healing Enhancement Products - Oxford Clinical Policy | 2024-10-01 |
| BCBS Oklahoma Medical Policies | Percutaneous and Subcutaneous Tibial Nerve Stimulation | 2024-10-01 |
| BCBS Oklahoma Medical Policies | Transcranial Magnetic Stimulation as a Treatment for | 2024-10-01 |
| BCBS New Mexico Medical Policies | Transcranial Magnetic Stimulation as a Treatment for | 2024-10-01 |
| BCBS New Mexico Medical Policies | Percutaneous and Subcutaneous Tibial Nerve Stimulation | 2024-10-01 |
| BCBS Montana Medical Policies | Percutaneous and Subcutaneous Tibial Nerve Stimulation | 2024-10-01 |
| BCBS Montana Medical Policies | Transcranial Magnetic Stimulation as a Treatment for | 2024-10-01 |